Maintenance of interleukin-21 enhancement of T and NK cell effector function in the presence of dexamethasone

被引：0
|
作者：
Krejsa, C. M. [1 ]
Wagener, F. D. [1 ]
Dodds, M. G. [1 ]
Janszen, D. B. [1 ]
Hughes, S. D. [1 ]
机构：
[1] ZymoGenetics Inc, Seattle, WA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.3070
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3070
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Interleukin-21 triggers effector cell responses in the gut
    Daniela De Nitto
    Massimiliano Sarra
    Francesco Pallone
    Giovanni Monteleone
    World Journal of Gastroenterology, 2010, 16 (29) : 3638 - 3641
  • [2] Interleukin-21 triggers effector cell responses in the gut
    De Nitto, Daniela
    Sarra, Massimiliano
    Pallone, Francesco
    Monteleone, Giovanni
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (29) : 3638 - 3641
  • [3] Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses
    Parrish-Novak, J
    Foster, DC
    Holly, RD
    Clegg, CH
    JOURNAL OF LEUKOCYTE BIOLOGY, 2002, 72 (05) : 856 - 863
  • [4] Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responses
    Monteleone, Giovanni
    Pallone, Francesco
    MacDonald, Thomas T.
    TRENDS IN IMMUNOLOGY, 2008, 29 (06) : 290 - 294
  • [5] Systems Modeling of the Role of Interleukin-21 in the Maintenance of Effector CD4+ T Cell Responses during Chronic Helicobacter pylori Infection
    Carbo, Adria
    Olivares-Villagomez, Danyvid
    Hontecillas, Raquel
    Bassaganya-Riera, Josep
    Chaturvedi, Rupesh
    Piazuelo, M. Blanca
    Delgado, Alberto
    Washington, M. Kay
    Wilson, Keith T.
    Algood, Holly M. Scott
    MBIO, 2014, 5 (04): : 1 - 11
  • [6] When playing the NK cell therapy card in glioblastoma, you can't beat interleukin-21
    Huntington, Nicholas D.
    CANCER CELL, 2024, 42 (08) : 1333 - 1335
  • [7] Interleukin-21 elicits durable T and NK cytotoxicity: Basic biology to clinical trials
    Sivakumar, P
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : S56 - S56
  • [8] Interleukin-21 enhances NK cell activation in response to antibody-coated targets
    Roda, Julie M.
    Parihar, Robin
    Lehman, Amy
    Mani, Aruna
    Tridandapani, Susheela
    Carson, William E., III
    JOURNAL OF IMMUNOLOGY, 2006, 177 (01): : 120 - 129
  • [9] Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD
    Shanley, Mayra
    Daher, May
    Dou, Jinzhuang
    Li, Sufang
    Basar, Rafet
    Rafei, Hind
    Dede, Merve
    Gumin, Joy
    Garcia, Jezreel Pantaleon
    Cortes, Ana Karen Nunez
    He, Shan
    Jones, Corry M.
    Acharya, Sunil
    Fowlkes, Natalie W.
    Xiong, Donghai
    Singh, Sanjay
    Shaim, Hila
    Hicks, Samantha Claire
    Liu, Bin
    Jain, Abhinav
    Zaman, Mohammad Fayyad
    Miao, Qi
    Li, Ye
    Uprety, Nadima
    Liu, Enli
    Muniz-Feliciano, Luis
    Deyter, Gary M.
    Mohanty, Vakul
    Zhang, Patrick
    Evans, Scott E.
    Shpall, Elizabeth J.
    Lang, Frederick F.
    Chen, Ken
    Rezvani, Katayoun
    CANCER CELL, 2024, 42 (08)
  • [10] Effect of interleukin-21 and dexamethasone on follicular helper T cells in patients with systemic lupus erythematosus
    陈京京
    ChinaMedicalAbstracts(InternalMedicine), 2013, 30 (04) : 202 - 203
12345